Skip to content

Frezyderm Nasal Ointment

by Frezyderm A.B.E.E. Greece EUDAMED

Ref 426104

EMDN Q030199

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-5202888261046Y5 Basic UDI-DIDate1 Sep 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Device Name
Frezyderm Nasal Ointment
Model / Reference
426104
Primary DI / UDI-DI
D-5202888261046Y5
Basic UDI-DI
B-5202888261046Y5
EMDN Code
Q030199 Nasopharyngeal devices - other
Device Class
Class IIa
Market of Registration
Greece

Manufacturer details

EUDAMED SRN
GR-MF-000026932

Other devices from Frezyderm A.B.E.E.

See all devices from Frezyderm A.B.E.E. →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED D-5202888261046Y5|B-5202888261046Y5 61 fields · synced 24 Oct 2026